Peter gasser swiss psychiatrist who founded

  • Dr.
  • Vice reports on LSD research in the 21st century, profiling MAPS-sponsored clinical psychedelic researcher Dr. Peter Gasser.
  • He is a physician for psychiatry and psychotherapy working in private practice in Solothurn, Switzerland.

    • •

    In 1988, Switzerland made therapy with psychedelic drugs legal. Five psychiatrists and psychotherapists were given permission to prescribe MDMA or LSD to their patients.

    It was a hell of an allowance, and at the time, shocked even the therapists who were involved.

    Videos by VICE

    “It was ganska surprising for everyone,” said Dr. Peter Gasser over the phone from his office in Switzerland. Dr. Gasser was a therapist in training in 1988 and he observed some of the sessions take place. “I think after that, no-one really knew why they got such permission. It was quite free, they could do what they wanted.”

    All five were members of the Swiss Medical Society for Psycholytic Therapy. The psycholytic method, pioneered by the German psychiatrist Hanscarl Leuner, calls for low doses of psychedelic drugs combined with talk therapy. The group also admired Stanislav Grof, a US based psychiatrist who favored large drug doses administered in silence or with music.

    •

    MindMed Adds Psychedelic Assisted Therapy specialist Dr. Peter Gasser As Clinical Advisor For Project Lucy

    Applauds Health Canada’s Approval Of Psilocybin Compassionate Access For Patients

    New York, fräsch, August 6, 2020 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has engagerad renowned psychedelic assisted therapy specialist Dr. Peter Gasser as an advisor to its LSD erfarenhetsbaserad therapy program Project Lucy.

    Dr. Gasser has pioneered the legal, medical use of psychedelics through clinical research and compassionate access in Switzerland. Dr Gasser has served as the President of the Swiss Medical Society for Psycholytic Therapy since 1997. Through compassionate access in Switzerland, Dr Gasser holds several individual treatment permissions to treat patients with MDMA and LSD.

    Dr. Gasser and University Hospital Basel’s Dr Matthias Liechti are conducting a Phase 2 trial of LSD assisted therapy for anxiety disorders. MindM

  • peter gasser swiss psychiatrist who founded

    • •

    Swiss Physicians Society for Psycholytic Therapy (SÄPT)

     

    The Swiss Physicians Society for Psycholytic Therapy (SÄPT) was founded in 1985 on the initiative of the Swiss psychiatrist Peter Baumann, MD, and fifteen physicians interested in these treatment methods. The aim of the association is to make the substances used in psycholytic and psychedelic psychotherapy accessible for psychotherapeutic use, to control their distribution, to stimulate their further research, and to provide theoretical and practical training necessary for their proper use. Today, the association has about 60 members, mainly from Switzerland and Germany.

    From 1988 to 1993, five SÄPT therapists were authorized by the Federal Office of Public Health (FOPH) to perform psycholytic therapies with MDMA and LSD in their practice. During these five years, approximately 170 patients were treated and more than one thousand substance-assisted therapy sessions were conducted. The largely posi